Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease

A. Bortoloti, M. M. Barzago, F. F. Stellari, M. Bonati, P. Introvini, F. Morandi, R. Zanini, G. Pagani, M. Palmieri, R. Rezzonico, G. Perotti, M. Maccabruni, M. Regazzoni, A. Auriemma, M. Teani, T. Fedeli, P. Tagliabue, N. Silliprandi

Research output: Contribution to journalArticle

Abstract

Deficiency of vitamin A (retinol) has been suggested as an important contributing cause in the pathogenesis of bronchopulmonary dysplasia (BPD) in premature newborns with severe lung disease. Although the efficacy of vitamin A supplementation has yet to be clearly confirmed, it is widely employed, at different dosages and schedules, in neonatal intensive care units (NICU). Since in Italy today no suitable formulation of vitamin A is available, the present observational study was designed to define the profile of plasma vitamin A and retinol-binding protein (RBP) concentrations in supplemented infants at risk for BPD admitted to seven Italian NICU. Twelve babies (average 27 weeks of gestation, birth weight 1,008 g), supplemented with vitamin A, were observed with sequential measurements of retinol and RBP up to 28 days of age. At birth retinol and RBP plasma concentrations were both adequate in the infants and half their mothers' levels. During supplementation the levels rose with wide variability according to the differences in dosing and timing in the different units. Plasma levels of retinol and RBP were the same in infants who had BPD and those who did not. A routine standardized therapeutic approach using vitamin A supplementation in Italian NICU will be more than welcome.

Original languageEnglish
Pages (from-to)144-151
Number of pages8
JournalDevelopmental Pharmacology and Therapeutics
Volume20
Issue number3-4
Publication statusPublished - 1993

Fingerprint

Vitamin A
Lung Diseases
Chronic Disease
Newborn Infant
Retinol-Binding Proteins
Bronchopulmonary Dysplasia
Neonatal Intensive Care Units
Plasma Retinol-Binding Proteins
Vitamin A Deficiency
Birth Weight
Italy
Observational Studies
Appointments and Schedules
Mothers
Parturition
Pregnancy

Keywords

  • Bronchopulmonary dysplasia
  • Plasma levels
  • Premature infants
  • Retinol-binding protein
  • Vitamin A

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bortoloti, A., Barzago, M. M., Stellari, F. F., Bonati, M., Introvini, P., Morandi, F., ... Silliprandi, N. (1993). Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease. Developmental Pharmacology and Therapeutics, 20(3-4), 144-151.

Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease. / Bortoloti, A.; Barzago, M. M.; Stellari, F. F.; Bonati, M.; Introvini, P.; Morandi, F.; Zanini, R.; Pagani, G.; Palmieri, M.; Rezzonico, R.; Perotti, G.; Maccabruni, M.; Regazzoni, M.; Auriemma, A.; Teani, M.; Fedeli, T.; Tagliabue, P.; Silliprandi, N.

In: Developmental Pharmacology and Therapeutics, Vol. 20, No. 3-4, 1993, p. 144-151.

Research output: Contribution to journalArticle

Bortoloti, A, Barzago, MM, Stellari, FF, Bonati, M, Introvini, P, Morandi, F, Zanini, R, Pagani, G, Palmieri, M, Rezzonico, R, Perotti, G, Maccabruni, M, Regazzoni, M, Auriemma, A, Teani, M, Fedeli, T, Tagliabue, P & Silliprandi, N 1993, 'Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease', Developmental Pharmacology and Therapeutics, vol. 20, no. 3-4, pp. 144-151.
Bortoloti, A. ; Barzago, M. M. ; Stellari, F. F. ; Bonati, M. ; Introvini, P. ; Morandi, F. ; Zanini, R. ; Pagani, G. ; Palmieri, M. ; Rezzonico, R. ; Perotti, G. ; Maccabruni, M. ; Regazzoni, M. ; Auriemma, A. ; Teani, M. ; Fedeli, T. ; Tagliabue, P. ; Silliprandi, N. / Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease. In: Developmental Pharmacology and Therapeutics. 1993 ; Vol. 20, No. 3-4. pp. 144-151.
@article{368e46568fd748dbaf6fe830bc2a9920,
title = "Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease",
abstract = "Deficiency of vitamin A (retinol) has been suggested as an important contributing cause in the pathogenesis of bronchopulmonary dysplasia (BPD) in premature newborns with severe lung disease. Although the efficacy of vitamin A supplementation has yet to be clearly confirmed, it is widely employed, at different dosages and schedules, in neonatal intensive care units (NICU). Since in Italy today no suitable formulation of vitamin A is available, the present observational study was designed to define the profile of plasma vitamin A and retinol-binding protein (RBP) concentrations in supplemented infants at risk for BPD admitted to seven Italian NICU. Twelve babies (average 27 weeks of gestation, birth weight 1,008 g), supplemented with vitamin A, were observed with sequential measurements of retinol and RBP up to 28 days of age. At birth retinol and RBP plasma concentrations were both adequate in the infants and half their mothers' levels. During supplementation the levels rose with wide variability according to the differences in dosing and timing in the different units. Plasma levels of retinol and RBP were the same in infants who had BPD and those who did not. A routine standardized therapeutic approach using vitamin A supplementation in Italian NICU will be more than welcome.",
keywords = "Bronchopulmonary dysplasia, Plasma levels, Premature infants, Retinol-binding protein, Vitamin A",
author = "A. Bortoloti and Barzago, {M. M.} and Stellari, {F. F.} and M. Bonati and P. Introvini and F. Morandi and R. Zanini and G. Pagani and M. Palmieri and R. Rezzonico and G. Perotti and M. Maccabruni and M. Regazzoni and A. Auriemma and M. Teani and T. Fedeli and P. Tagliabue and N. Silliprandi",
year = "1993",
language = "English",
volume = "20",
pages = "144--151",
journal = "Developmental Pharmacology and Therapeutics",
issn = "0379-8305",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease

AU - Bortoloti, A.

AU - Barzago, M. M.

AU - Stellari, F. F.

AU - Bonati, M.

AU - Introvini, P.

AU - Morandi, F.

AU - Zanini, R.

AU - Pagani, G.

AU - Palmieri, M.

AU - Rezzonico, R.

AU - Perotti, G.

AU - Maccabruni, M.

AU - Regazzoni, M.

AU - Auriemma, A.

AU - Teani, M.

AU - Fedeli, T.

AU - Tagliabue, P.

AU - Silliprandi, N.

PY - 1993

Y1 - 1993

N2 - Deficiency of vitamin A (retinol) has been suggested as an important contributing cause in the pathogenesis of bronchopulmonary dysplasia (BPD) in premature newborns with severe lung disease. Although the efficacy of vitamin A supplementation has yet to be clearly confirmed, it is widely employed, at different dosages and schedules, in neonatal intensive care units (NICU). Since in Italy today no suitable formulation of vitamin A is available, the present observational study was designed to define the profile of plasma vitamin A and retinol-binding protein (RBP) concentrations in supplemented infants at risk for BPD admitted to seven Italian NICU. Twelve babies (average 27 weeks of gestation, birth weight 1,008 g), supplemented with vitamin A, were observed with sequential measurements of retinol and RBP up to 28 days of age. At birth retinol and RBP plasma concentrations were both adequate in the infants and half their mothers' levels. During supplementation the levels rose with wide variability according to the differences in dosing and timing in the different units. Plasma levels of retinol and RBP were the same in infants who had BPD and those who did not. A routine standardized therapeutic approach using vitamin A supplementation in Italian NICU will be more than welcome.

AB - Deficiency of vitamin A (retinol) has been suggested as an important contributing cause in the pathogenesis of bronchopulmonary dysplasia (BPD) in premature newborns with severe lung disease. Although the efficacy of vitamin A supplementation has yet to be clearly confirmed, it is widely employed, at different dosages and schedules, in neonatal intensive care units (NICU). Since in Italy today no suitable formulation of vitamin A is available, the present observational study was designed to define the profile of plasma vitamin A and retinol-binding protein (RBP) concentrations in supplemented infants at risk for BPD admitted to seven Italian NICU. Twelve babies (average 27 weeks of gestation, birth weight 1,008 g), supplemented with vitamin A, were observed with sequential measurements of retinol and RBP up to 28 days of age. At birth retinol and RBP plasma concentrations were both adequate in the infants and half their mothers' levels. During supplementation the levels rose with wide variability according to the differences in dosing and timing in the different units. Plasma levels of retinol and RBP were the same in infants who had BPD and those who did not. A routine standardized therapeutic approach using vitamin A supplementation in Italian NICU will be more than welcome.

KW - Bronchopulmonary dysplasia

KW - Plasma levels

KW - Premature infants

KW - Retinol-binding protein

KW - Vitamin A

UR - http://www.scopus.com/inward/record.url?scp=0027721789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027721789&partnerID=8YFLogxK

M3 - Article

C2 - 7828446

VL - 20

SP - 144

EP - 151

JO - Developmental Pharmacology and Therapeutics

JF - Developmental Pharmacology and Therapeutics

SN - 0379-8305

IS - 3-4

ER -